Before you watch this webinar
Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.
This area of the website is reserved for healthcare professionals as it contains information created for a healthcare professional audience.
Event
Chemical or biochemical markers of responders to Rituximab
Please note: There is restricted access to the live webinars. Access to the live webinars is for health professionals and a limited number of pharmaceutical representatives. If you are not granted access to the live webinar, you will be able to review a recording of the Neuromuscular Academy session, which will be posted on our website shortly after the webinar has been conducted.
Our sponsor
This webinar has received sponsorship from argenx UK limited. The first session in the webinar is designed and delivered by the Neurology Academy and sponsored by argenx UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by argenx UK limited. This satellite symposium is for UK Healthcare Professionals only.
Neuromuscular Academy will host a live webinar on Thursday 17th October at 16:00. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour and 40 minutes via Zoom and a recording of the Neuromuscular Academy session will be available following the meeting.
16:00 - 16:45 - Neuromuscular Academy session
16:45 - 16:50 - Break
16:50 - 17:40 - argenx promotional satellite symposium
Neuromuscular Academy session
Topics for discussion
- What are your trigger points?
- What are the checkpoints?
- Factors to help identify who might respond better to B cell therapies.
- How can we identify earlier who might respond better to Rituximab?
Dr Channa Hewamadduma
Consultant neurologist and honorary senior lecturer, Sheffield Teaching Hospitals NHS Foundation Trust
Dr John McConville
Consultant neurologist, Belfast Health and Social Care Trust
Natasha Hoyle
Lead neurosciences pharmacist, Sheffield Teaching Hospitals NHS Foundation Trust.
This webinar has received sponsorship from argenx UK limited. The first session in the webinar is designed and delivered by the Neurology Academy and sponsored by argenx UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by argenx UK limited. This satellite symposium is for UK Healthcare Professionals only.
argenx promotional satellite symposium
16:50 – 16:55 - Welcome and Agenda
Dr Channa Hewamadduma
16:55 – 17:05 - Early vs. Late Control of MG Symptoms – The Patient Perspective
Charlotte Campbell, Research & Partnerships Officer, MyAware
17:05 – 17:20 - Early vs. Late Control of MG Symptoms – The Clinical Perspective
Georgiana Logou, Myasthenia Gravis Clinical Nurse Specialist, Queen Square London
17:20 – 17:30 - ABN Guideline Update
Prof Saiju Jacob, Consultant Neurologist and Hon. Prof. of Neuroimmunology, University Hospitals Birmingham
17:30 – 17:40 - Panel Discussion
Whole panel, facilitated by Chair
UK-EFG-24-00069 Date of Prep: September 2024
Dr Channa Hewamadduma
Consultant neurologist and honorary senior lecturer, Sheffield Teaching Hospitals NHS Foundation Trust
Charlotte Campbell
Research and partnerships officer, Myaware
Georgiana Logou
Myasthenia gravis clinical nurse specialist, University College London Hospitals NHS Foundation Trust
Prof Saiju Jacob
Consultant neurologist, University Hospitals Birmingham
This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.
Book your place now
Our sponsor
This webinar has received sponsorship from argenx UK limited. The first session in the webinar is designed and delivered by the Neurology Academy and sponsored by argenx UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by argenx UK limited. This satellite symposium is for UK Healthcare Professionals only.
Raising awareness, improving outcomes
Neuromuscular Academy is the first bespoke course for healthcare professionals to receive expert training in neuromuscular conditions like spinal muscular atrophy.